Rise in Awareness Related to Artificial Intelligence Expected to Drive Europe Artificial Intelligence (AI) in Drug Discovery Market: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit The artificial intelligence (AI) in drug discovery market includes sale of AI for drug discovery and other related services. AI based technology uses a simulation of human intelligence to process by machines for tackling the complex problems in drug discovery process. It also helps in finding new molecules for identifying the drug targets and developing the personalized medicines for the pharmaceutical industry. Artificial intelligence helps in improving the drug approval rates, less cost of development, swift availability of medications and helping the patients to comply with treatments. Moreover, the rising need to decrease the overall cost of drug discovery and the approval process requiring lot of human expertise and time, much eased by the use of AI based techniques. As per analysis, “Europe Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity” the key companies operating in the Europe Artificial Intelligence (AI) in drug discovery market include Google, Berg LLC, Exscientia, Berg LLC, Numedii, Inc., BIOAGE, IBM Corporation, Xtalpi, Inc., Cyclica, Cloud Pharmaceuticals, Inc., Owkin, Inc., Atomwise, Inc., Google, Microsoft Corporation, NVIDIA Corporation, Envisagenics, Insilico Medicine, Numerate, Twoxar, Deep Genomics, Incorporated, Verge Genomics and among others. Major companies are adopting various strategic collaborations to research & discover drugs using artificial intelligence and are gaining considerable popularity in the artificial intelligence in drug discovery market. Based on therapeutic area, Europe Artificial Intelligence (AI) in drug discovery market is divided into metabolic diseases, neurodegenerative diseases, oncology and cardiovascular diseases. Based on drug type, market is divided into small & large molecule drugs. Based on technology type, market is divided into supervised & unsupervised learning, deep learning, reinforcement learning and other technologies. Based on application, market is divided into drug design, clinical trials, information & data analysis, drug evaluation and other applications. Based on offering type, market is divided into software and services offering. Additionally, on the basis of industry vertical, market is divided into pharmaceutical & biotechnology companies, contract research organizations and academic & research institutes and others. The Europe Artificial Intelligence (AI) in drug discovery market is driven by huge amount of data generated during small molecule screening & preclinical studies, followed by growth in adoption of cloud based services & applications, increase in availability of options to carry out data mining and various specific customizations according to the need and growth in advancements in AI such as machine learning and artificial neural networks. However, limited acceptance from healthcare professionals is a major hindering factor for market. Moreover, increase in awareness related to artificial intelligence among pharmaceutical manufacturers and expansion of biotechnology industries are key opportunities for market. Furthermore, lack of data sets and unavailability of skilled labors are major challenges for market. It is anticipated that the Europe Artificial Intelligence (AI) in drug discovery market will be reached at rapid pace owing to presence of major players operating in the countries, growth of pharmaceutical industries by collaborations with other industries, and rise in availability of developed infrastructure in order to facilitate adoption of AI during the forecast period. For More Information, click on the link below:- Europe Artificial Intelligence in Drug Discovery Market Research Report Related Report:- Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications ankur@kenresearch.com +91-9015378249 Post Views: 4 Tags: Artificial Intelligence in Drug Discovery Industry in Europe, Artificial Intelligence in Drug Discovery Market in Europe, Atomwise Inc. Artificial Intelligence in Drug Discovery Market, BenevolentAI Artificial Intelligence in Drug Discovery Market, Berg LLC Artificial Intelligence in Drug Discovery Market, Bioage Artificial Intelligence in Drug Discovery Market, Cloud Pharmaceuticals Inc. Artificial Intelligence in Drug Discovery Market, Cyclica Artificial Intelligence in Drug Discovery Market, Deep Genomics Artificial Intelligence in Drug Discovery Market, Envisagenics Artificial Intelligence in Drug Discovery Market, Europa Inteligencia artificial en el mercado de descubrimiento de fármacos, Europe AI in Drug Discovery Industry, Europe AI in Drug Discovery Market, Europe Artificial Intelligence in Drug Discovery Industry, Europe Artificial Intelligence in Drug Discovery Industry Research, Europe Artificial Intelligence in Drug Discovery Industry Research Report, Europe Artificial Intelligence in Drug Discovery Market, Europe Artificial Intelligence in Drug Discovery Market Analysis, Europe Artificial Intelligence in Drug Discovery Market Forecast, Europe Artificial Intelligence in Drug Discovery Market Future Outlook, Europe Artificial Intelligence in Drug Discovery Market Growth, Europe Artificial Intelligence in Drug Discovery Market Key Players, Europe Artificial Intelligence in Drug Discovery Market Research, Europe Artificial Intelligence in Drug Discovery Market Research Report, Europe Artificial Intelligence in Drug Discovery Market Revenue, Europe Artificial Intelligence in Drug Discovery Market Scope, Europe Artificial Intelligence in Drug Discovery Market Share, Europe Artificial Intelligence in Drug Discovery Market Size, Europe Artificial Intelligence in Drug Discovery Market Trends, Exscientia Artificial Intelligence in Drug Discovery Market, France Artificial Intelligence in Drug Discovery Market, Germany Artificial Intelligence in Drug Discovery Market, Global Artificial Intelligence in Drug Discovery Industry, Global Artificial Intelligence in Drug Discovery Market, Google Artificial Intelligence in Drug Discovery Market, IBM Corporation Artificial Intelligence in Drug Discovery Market, Insilico Medicine Artificial Intelligence in Drug Discovery Market, Intelligenza artificiale in Europa nel mercato della scoperta dei farmaci, Italy Artificial Intelligence in Drug Discovery Market, Künstliche Intelligenz in Europa im Markt für Arzneimittelforschung, L'intelligence artificielle en Europe sur le marché de la découverte de médicaments, Microsoft Corporation Artificial Intelligence in Drug Discovery Market, Numedii Inc. Artificial Intelligence in Drug Discovery Market, Numerate Artificial Intelligence in Drug Discovery Market, NVIDIA Corporation Artificial Intelligence in Drug Discovery Market, Owkin Inc. Artificial Intelligence in Drug Discovery Market, Portugal Artificial Intelligence in Drug Discovery Market, Spain Artificial Intelligence in Drug Discovery Market, Twoxar Incorporated Artificial Intelligence in Drug Discovery Market, Verge Genomics Artificial Intelligence in Drug Discovery Market, Xtalpi Inc. Artificial Intelligence in Drug Discovery Market